It's also important to remember that the trial is targeted to patients who have exhausted all other treatment options. These patients would I suspect
be quite ill which highlights the need to carefully screen to ensure your patient are not going to die regardless of the treatment. A death in a safety trial is not a good look.
Cheers Icharus